The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The primary objective is to determine if there is a significant increase in the haematocrit
value of patients on Jobelyn and standard therapy compared to those on standard therapy
alone.